Viewing nowOlmefant Table 10mg (Olmesartan Medoxomil)
Olmesartan Medoxomil 10mg
Tablet · Prescription medication
Korea United Pharm, Inc.

MFDS item code 201100952 · Approved 2011.02.25 · Insurance code 644308130
Treatment of essential hypertension
Essential hypertension is a condition where blood pressure is persistently high, which can affect heart and vascular health. This medication helps effectively lower blood pressure and prevent cardiovascular complications. Regular intake facilitates blood pressure control and reduces discomfort in daily life. It also alleviates the burden on the heart and helps maintain healthy blood vessels. It is used for the treatment of essential hypertension.
<Adults> The recommended initial dose is 10mg once daily, with or without food. If blood pressure is not adequately controlled at this dose, the dose may be increased to 20mg once daily. If additional blood pressure reduction is required, the dose may be increased to a maximum of 40mg once daily. The blood pressure-lowering effect appears within 2 weeks after starting treatment and reaches its maximum effect at about 8 weeks. If blood pressure is not controlled with this drug alone, it may be administered in combination with a thiazide diuretic such as hydrochlorothiazide. To improve adherence, it is recommended that the drug be taken at the same time each day, if possible (e.g., in the morning). For patients who may have intravascular volume depletion (e.g., patients taking diuretics, especially those with renal impairment), it is recommended that treatment be initiated at a low dose while their condition is carefully monitored. <Elderly patients> No dose adjustment is required when this drug is administered to elderly patients aged 65 years or older. Although no overall differences in the efficacy and safety of this drug have been observed between elderly and younger patients, a more sensitive response in some elderly patients cannot be ruled out. <Patients with renal impairment> The maximum dose for patients with mild or moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. <Patients with hepatic impairment> No dose adjustment is required for patients with mild hepatic impairment. The recommended initial dose for patients with moderate hepatic impairment is 10mg once daily, which may be increased to a maximum of 20mg once daily. As there is no experience with use in patients with severe hepatic impairment, administration of this drug is not recommended.
Safety and efficacy in children have not been established.
This medication may cause severe harm or even death to the fetus and neonate when administered to pregnant women in the second and third trimesters, hence, it should be discontinued immediately upon confirmation of pregnancy. People who are allergic to this medication or its components, pregnant or breastfeeding women, patients undergoing renal dialysis, those with severe liver impairment, patients with biliary obstruction, and individuals with lactose intolerance should not use this medication. Patients with reduced blood volume or low sodium levels may experience hypotension, therefore, their condition should be checked thoroughly before beginning treatment, and appropriate measures should be taken immediately if hypotension occurs. Patients with impaired renal function or kidney transplant recipients should have their renal function and electrolyte status regularly monitored through blood tests, and it is not recommended for patients with severe renal impairment. Since this medication lowers blood pressure, patients with aortic stenosis or hypertrophic obstructive cardiomyopathy should use it with caution, and dizziness might occur due to blood pressure reduction, hence driving or operating dangerous machinery should be avoided. Side effects such as dizziness, headaches, chest pain, dyspepsia, muscle pain, and rash may occur during the course of treatment, and, although rare, angioedema or liver function abnormalities may also arise. If chronic diarrhea and weight loss persist, this medication may be responsible, and immediate consultation with healthcare professionals is needed; if intestinal angioedema symptoms appear, discontinue use and seek appropriate treatment. Co-administration of potassium-sparing diuretics or potassium supplements may cause dangerously high potassium levels, thus potassium levels should be regularly monitored through blood tests when used together. Additionally, co-administration with lithium or non-steroidal anti-inflammatory drugs (NSAIDs) may increase the risk of side effects, so healthcare providers must be notified. During pregnancy, especially, there are risks of fetal renal function reduction and amniotic fluid decrease, so it's safer not to use this medication if pregnancy is planned or possible. In breastfeeding, this medication may be partially transferred to breast milk and can cause adverse reactions in infants, hence it's recommended to discontinue either breastfeeding or this medication. Safety has not been established in pediatric populations, so it should not be used in children. Overdosage may cause symptoms such as hypotension and palpitations, so if these symptoms occur, immediate medical attention should be sought for appropriate treatment.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture. It is important to maintain room temperature between 1 and 25 degrees Celsius to preserve the efficacy and safety of the medication.
White round film-coated tablet
30 tablets per bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowOlmesartan Medoxomil 10mg
Tablet · Prescription medication
Korea United Pharm, Inc.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
JW Pharmaceutical Corporation

Olmesartan Medoxomil 40mg
Tablet · Prescription medication
JW Pharmaceutical Corp.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
JW Pharmaceutical Corporation

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Dongkuk Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
DongKook Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.